deaths from glp 1 GLP-1 medications get at the heart of addiction: study – WashU Medicine Glucagon-like peptide-1 receptor agonists and

To detect GLP-1 secretion from enteroendocrine cell supernatants, we exploit a reporter cell line that expresses the recombinant GLP-1 receptor in combination with the chAMPion reporter system in a CHO background

Reported Issues: Consumers report: That the supplement did not lead to weight loss or appetite suppression as advertised That the product was marketed using misleading claims about GLP-1 support That they paid for a product that did not provide the promised benefits That the supplements are promoted as alternatives to GLP-1 medications, despite not functioning like prescription GLP-1 drugs That marketing materials imply that these supplements are scientifically and medically proven and reliable, when evidence may be lacking That they would not have purchased the supplements if they had known the claims were not supported by reliable scientific evidence Experiencing adverse side effects such as stomach pain or bloating Why Individuals Should Be Concerned: Potential claims include: Economic loss False advertising Safety risk Product defect Performance vs

Vahl TP, Paty BW, Fuller BD, Prigeon RL, DAlessio DA (2003) Effects of GLP-1-(736)NH2, GLP-1-(737), and GLP-1- (936)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans

Increased endurance helps the body endure physical activity longer, especially during aerobic training

[PMID: 25310338] PubMed record related to this compound for laboratory literature review